Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gizem Akçay
Observed names:
Akcay, Gizem,
Gizem Akcay
Observed institutions:
Tufts University,
AstraZeneca (United States),
Massachusetts Institute of Technology
OpenAlex ID:
A5050582425
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
2016
·
Gizem Akçay
, Matthew A Belmonte
, et al.
·
Nature Chemical Biology
·
207
Translocation of Non-Canonical Polypeptides into Cells Using Protective Antigen
2015
·
Amy E. Rabideau
, Xiaoli Liao
, et al.
·
Scientific Reports
·
25
PDF
A new paradigm for protein design and biological self-assembly
2009
·
Gizem Akçay
, Krishna Kumar
·
Journal of Fluorine Chemistry
·
24
Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists
2022
·
Douglas L. Orsi
, Steven J. Ferrara
, et al.
·
Bioorganic & Medicinal Chemistry
·
18
PDF
Total synthesis of trifluorobutyryl-modified, protected sialyl Lewis X by a convergent [2+2] approach
2014
·
Gizem Akçay
, John Y. Ramphal
, et al.
·
Tetrahedron Letters
·
15
Abstract A06: Biophysical and biochemical characterization of KRAS G12C inhibition through the SMARTTM platform
2020
·
Minyun Zhou
, Alexander Yuzhakov
, et al.
·
Molecular Cancer Research
·
1
Abstract C40: Inhibition of Mcl-1 through covalent modification of a non-catalytic lysine side chain
2015
·
Qibin Su
, Gizem Akçay
, et al.
·
Molecular Cancer Therapeutics
·
1
Abstract 2682: Small molecule targeting the lipoic acid post-translational modification impacts proliferation of colorectal and PIK3CA-mutant cell lines
2022
·
Laura Doherty
, Tenzin Sangpo
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
291
H-index:
5
I10-index:
5
Year
Topic
Type